
Steven P. Griffin
Examiner (ID: 967)
| Most Active Art Unit | 1303 |
| Art Unit(s) | 1731, 1303, 1791, 1754 |
| Total Applications | 536 |
| Issued Applications | 367 |
| Pending Applications | 79 |
| Abandoned Applications | 90 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17290829
[patent_doc_number] => 20210386668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => Cyclodextrin for use in the treatment and prevention of late phase bronchoconstriction in allergen-induced asthma
[patent_app_type] => utility
[patent_app_number] => 17/347683
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347683
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347683 | Cyclodextrin for use in the treatment and prevention of late phase bronchoconstriction in allergen-induced asthma | Jun 14, 2021 | Abandoned |
Array
(
[id] => 18522896
[patent_doc_number] => 20230233545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => TREATMENT OF ATRIAL DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/001896
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001896 | TREATMENT OF ATRIAL DYSFUNCTION | Jun 13, 2021 | Pending |
Array
(
[id] => 19150204
[patent_doc_number] => 11975094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Three-part makeup remover compositions
[patent_app_type] => utility
[patent_app_number] => 17/340343
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7085
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340343 | Three-part makeup remover compositions | Jun 6, 2021 | Issued |
Array
(
[id] => 18075732
[patent_doc_number] => 20220401344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS
[patent_app_type] => utility
[patent_app_number] => 17/332695
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/332695 | COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS | May 26, 2021 | Pending |
Array
(
[id] => 19423815
[patent_doc_number] => 12083206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Hair treatment compositions
[patent_app_type] => utility
[patent_app_number] => 17/331904
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 18594
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331904 | Hair treatment compositions | May 26, 2021 | Issued |
Array
(
[id] => 18019037
[patent_doc_number] => 20220370536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Preventing, treating, and curing illness by denaturing proteins and nucleic acids
[patent_app_type] => utility
[patent_app_number] => 17/328992
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328992
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328992 | Preventing, treating, and curing illness by denaturing proteins and nucleic acids | May 23, 2021 | Abandoned |
Array
(
[id] => 18466833
[patent_doc_number] => 20230201113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => IMMUNE BOOSTER - SUPPLEMENT TREATMENT KIT AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/998694
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998694 | IMMUNE BOOSTER - SUPPLEMENT TREATMENT KIT AND METHODS OF USE | May 13, 2021 | Pending |
Array
(
[id] => 17441657
[patent_doc_number] => 20220062162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Toner, Lysozyme Buccal Tablet and Preparation Method of Lysozyme Buccal Tablet
[patent_app_type] => utility
[patent_app_number] => 17/319113
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319113 | Toner, Lysozyme Buccal Tablet and Preparation Method of Lysozyme Buccal Tablet | May 12, 2021 | Abandoned |
Array
(
[id] => 17095258
[patent_doc_number] => 20210283049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => INTRAVENOUS SOTALOL HYDROCHLORIDE LOADING AND MAINTENANCE FOR CARDIAC SURGERY PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/306490
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306490
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/306490 | INTRAVENOUS SOTALOL HYDROCHLORIDE LOADING AND MAINTENANCE FOR CARDIAC SURGERY PATIENTS | May 2, 2021 | Pending |
Array
(
[id] => 19186238
[patent_doc_number] => 20240165151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING UPPER RESPIRATORY INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/920984
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920984 | COMPOSITIONS AND METHODS FOR TREATING UPPER RESPIRATORY INFECTIONS | Apr 21, 2021 | Abandoned |
Array
(
[id] => 17034250
[patent_doc_number] => 20210251208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITION AND METHOD FOR ATTRACTING BED BUGS
[patent_app_type] => utility
[patent_app_number] => 17/236769
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236769 | COMPOSITION AND METHOD FOR ATTRACTING BED BUGS | Apr 20, 2021 | Abandoned |
Array
(
[id] => 17168794
[patent_doc_number] => 20210322464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHOD OF TREATING AND PREVENTING CORONAVIRUS DISEASE 19 (COVID-19) USING A SELENIUM ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/235592
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/235592 | METHOD OF TREATING AND PREVENTING CORONAVIRUS DISEASE 19 (COVID-19) USING A SELENIUM ADMINISTRATION | Apr 19, 2021 | Abandoned |
Array
(
[id] => 17368152
[patent_doc_number] => 20220023204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE
[patent_app_type] => utility
[patent_app_number] => 17/235771
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235771
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/235771 | BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE | Apr 19, 2021 | Pending |
Array
(
[id] => 17168683
[patent_doc_number] => 20210322353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => NUTRITIONAL COMPOSITION FOR THE TREATMENT OF METABOLIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/233031
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233031 | NUTRITIONAL COMPOSITION FOR THE TREATMENT OF METABOLIC DISEASES | Apr 15, 2021 | Abandoned |
Array
(
[id] => 17154756
[patent_doc_number] => 20210315807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => HYDROGEL COMPOSITION AND HYDROGEL LENS
[patent_app_type] => utility
[patent_app_number] => 17/227381
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227381 | HYDROGEL COMPOSITION AND HYDROGEL LENS | Apr 11, 2021 | Pending |
Array
(
[id] => 18374374
[patent_doc_number] => 20230149453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune/inflammatory diseases in humans or animals
[patent_app_type] => utility
[patent_app_number] => 17/995021
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9538
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995021 | Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune/inflammatory diseases in humans or animals | Apr 5, 2021 | Abandoned |
Array
(
[id] => 17227007
[patent_doc_number] => 20210353563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOSITION AND METHOD FOR TREATMENT OF RESPIRATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/214360
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214360 | COMPOSITION AND METHOD FOR TREATMENT OF RESPIRATORY DISORDERS | Mar 25, 2021 | Pending |
Array
(
[id] => 18877364
[patent_doc_number] => 20240000733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => COMPOSITION AND METHOD FOR TREATMENT OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/527401
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527401
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527401 | COMPOSITION AND METHOD FOR TREATMENT OF DIABETES | Mar 23, 2021 | Abandoned |
Array
(
[id] => 18018899
[patent_doc_number] => 20220370398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD TO DESTABALIZE CYSTEINE EXPOSED INFECTIOUS INFORMATION VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/210366
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210366 | METHOD TO DESTABALIZE CYSTEINE EXPOSED INFECTIOUS INFORMATION VECTORS | Mar 22, 2021 | Pending |
Array
(
[id] => 17546695
[patent_doc_number] => 20220118036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => USE OF MORCHELLA ACTIVE SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 17/198928
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198928 | USE OF MORCHELLA ACTIVE SUBSTANCE | Mar 10, 2021 | Abandoned |